Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Oncotherapy Science Inc patents


Recent patent applications related to Oncotherapy Science Inc. Oncotherapy Science Inc is listed as an Agent/Assignee. Note: Oncotherapy Science Inc may have other listings under different names/spellings. We're not affiliated with Oncotherapy Science Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Oncotherapy Science Inc-related inventors


Cdca1-derived peptide and vaccine containing same

The present invention provides cdca1-derived epitope peptides having the ability to induce cytotoxic t cells. The present invention further provides polynucleotides encoding the peptides, antigen-presenting cells presenting the peptides, and cytotoxic t cells targeting the peptides, as well as methods of inducing the antigen-presenting cells or ctls. ... Oncotherapy Science Inc

Urlc10-derived peptide and vaccine containing same

The present invention provides urlc10-derived epitope peptides having the ability to induce cytotoxic t cells. The present invention further provides polynucleotides encoding the peptides, antigen-presenting cells presenting the peptides, and cytotoxic t cells targeting the peptides, as well as methods of inducing the antigen-presenting cells or ctls. ... Oncotherapy Science Inc

Imp-3 epitope peptides for th1 cells and vaccines containing the same

Isolated imp-3-derived epitope peptides having th1 cell inducibility are disclosed herein. In preferred embodiments, such a peptide of the present invention can promiscuously bind to mhc class ii molecules and induce imp-3-specific cytotoxic t lymphocytes (ctls) in addition to th1 cells. ... Oncotherapy Science Inc

Gpc3 epitope peptides for th1 cells and vaccines containing the same

Isolated gpc3-derived epitope peptides having th1 cell inducibility are disclosed herein. Such peptides can be recognized by mhc class ii molecules and induce th1 cells. ... Oncotherapy Science Inc

Koc1-derived peptide and vaccine including same

The present invention provides koc1-derived epitope peptides having the ability to induce cytotoxic t cells. The present invention further provides polynucleotides encoding the peptides, antigen-presenting cells presenting the peptides, and cytotoxic t cells targeting the peptides, as well as methods of inducing the antigen-presenting cells or ctls. ... Oncotherapy Science Inc

Cdca1 epitope peptides for th1 cells and vaccines containing the same

Isolated cdca1-derived epitope peptides having th1 cell inducibility are disclosed herein. Such peptides can be recognized by mhc class ii molecules and induce th1 cells. ... Oncotherapy Science Inc

Tomm34 peptides and vaccines including the same

The present invention provides isolated peptides or the fragments derived from seq id no: 42, which bind to an hla antigen and induce cytotoxic t lymphocytes (ctl). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. ... Oncotherapy Science Inc

Kif20a epitope peptides for th1 cells and vaccines containing the same

Isolated kif20a-derived epitope peptides having th1 cell inducibility are disclosed herein. Such peptides can be recognized by mhc class ii molecules and induce th1 cells. ... Oncotherapy Science Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Oncotherapy Science Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Oncotherapy Science Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###